Atlas Trials

Advanced Malignant Solid Tumor

37 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Malignant Solid Tumor

RecordFirmDate
A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors. (NCT05396339)SUNHO（China）BioPharmaceutical CO., Ltd.2022-06-24
First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors (NCT05098405)Molecular Partners AG2021-10-11
PRL3-Zumab in Patients With Advanced Solid Tumors (NCT07541001)Intra-IMMUSG Pte Ltd2021-08-30
Clinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors (NCT04758897)CNBG-Virogin Biotech (Shanghai) Ltd.2021-04-14
Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors (NCT04864379)Sir Run Run Shaw Hospital2020-09-03
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets (NCT04275050)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2020-04-01
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function (NCT04241835)Epizyme, Inc.2020-01-15
Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor (NCT03662815)Sir Run Run Shaw Hospital2018-02-07
Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors (NCT03171220)The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2017-06-01

Track Advanced Malignant Solid Tumor automatically

Every clearance here is in the API, with alerts when new ones post.